MYCN drives oncogenesis by cooperating with the histone methyltransferase G9a and the WDR5 adaptor to orchestrate global gene transcription.
MYCN activates canonical MYC targets involved in ribosome biogenesis, protein synthesis, and represses neuronal differentiation genes to drive oncogenesis in neuroblastoma (NB). How MYCN orchestrates global gene expression remains incompletely understood. Our study finds that MYCN binds promoters to...
Main Authors: | Zhihui Liu, Xiyuan Zhang, Man Xu, Jason J Hong, Amanda Ciardiello, Haiyan Lei, Jack F Shern, Carol J Thiele |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-03-01
|
Series: | PLoS Biology |
Online Access: | https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3002240&type=printable |
Similar Items
-
Aberrant Activity of Histone–Lysine N-Methyltransferase 2 (KMT2) Complexes in Oncogenesis
by: Elzbieta Poreba, et al.
Published: (2020-12-01) -
Loss of CASZ1 tumor suppressor linked to oncogenic subversion of neuroblastoma core regulatory circuitry
by: Zhihui Liu, et al.
Published: (2022-10-01) -
Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases.
by: Rajnee Kanwal, et al.
Published: (2016-01-01) -
A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts.
by: Dustin, M, et al.
Published: (1998) -
BRAF inhibition in melanoma is associated with the dysregulation of histone methylation and histone methyltransferases
by: Florina Grigore, et al.
Published: (2020-09-01)